CRIZAC LIMITED
NSE: CRIZACMarket Closed • NSE
Day range
52 week range
CRIZAC LIMITED closed at INR156.35 (+2.63%) on volume 1.06x its 20-day average, trading 53.05% below its 52-week high.
2026-Q2
Q2 FY2026 Financial Results
PAT moved -37.2% QoQ
2026-02-04
DIVIDEND Announced
Interim Dividend - Rs 8 Per Share
Revenue and PAT bars use independent scales to make their year-on-year direction readable.
Complete reported financial history · Values use the company's reporting currency
Hover over the chart for exact reported values. Percentage lines use the right-hand axis.
A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.
Strengths
Low Debt Profile: Debt-to-Equity is comfortable at 0.31x
Attractive Valuation: P/E of 12.4x trades below sector historical averages
Risks
Subject to cyclical raw material and macro industry pressures
Bull case
Market Leadership: Established operational scale in Education & Training Services.
Bear case
Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.
Flip condition
Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.
Complete dividend, bonus, split, rights and other action history
| Record date | Corporate action | Information | Announcement date | Ex-date |
|---|---|---|---|---|
| 04 Feb 2026 | Dividend | ₹8.00 / share | — | 04 Feb 2026 |
Traded volume and delivery percentage across the latest 20 sessions
Compare valuation, latest quarterly performance and year-on-year growth
| Company name | Market cap ₹ Cr | P/E ratio | Dividend yield % | Quarterly sales ₹ Cr | Profit after tax ₹ Cr | Sales growth % | Profit growth % |
|---|---|---|---|---|---|---|---|
Hindustan Unilever LimitedHINDUNILVR Open analysis | ₹4.45L | 42.46 | 2.32% | ₹17,341.00 | ₹2,680.00 | +10.05% | -3.18% |
ITC LimitedITC Open analysis | ₹3.30L | 16.64 | 6.06% | ₹19,114.00 | ₹4,509.00 | -11.08% | -15.61% |
Nestlé India LimitedNESTLEIND Open analysis | ₹2.44L | 59.83 | 0.94% | ₹6,378.00 | ₹959.00 | +25.16% | +48.22% |
Avenue Supermarts LimitedDMART Open analysis | ₹2.18L | 69.89 | 0.00% | ₹18,795.00 | ₹860.00 | +14.88% | +11.25% |
Varun Beverages LimitedVBL Open analysis | ₹1.46L | 43.05 | 0.47% | ₹8,451.00 | ₹1,525.00 | +20.44% | +15.09% |
Britannia Industries LimitedBRITANNIA Open analysis | ₹1.15L | 44.07 | 1.87% | ₹5,000.00 | ₹593.00 | +8.18% | +14.04% |
Marico LimitedMARICO Open analysis | ₹1.02L | 53.91 | 0.51% | ₹3,957.00 | ₹652.00 | +22.85% | +27.10% |
UNITED SPIRITS LIMITEDUNITDSPR Open analysis | ₹97,987.65 | 58.11 | 1.23% | ₹3,054.00 | ₹539.00 | +3.67% | +28.03% |
Crizac Limited provides educational consultancy services in India and internationally. The company offers student recruitment solutions to global institutions of higher education in the United Kingdom, Canada, Republic of Ireland, Australia, and New Zealand. It also provides marketing, brand management, and admission office management services. The company was incorporated in 2011 and is based in Kolkata, India.
IndiaConsumer Defensive
Is CRIZAC LIMITED Shariah compliant?
CRIZAC LIMITED is currently screened as Shariah Compliant under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (0.07%) complies with AAOIFI threshold (≤ 33%).
What is CRIZAC LIMITED's current valuation relative to peers?
CRIZAC LIMITED trades at a P/E of 12.4x compared to the sector median of 21.9x, and a Price-to-Book of 4.7x.
Is the company financially healthy?
The company has a Debt-to-Equity ratio of 0.31x. Interest coverage is 3876.3x.
What are the historical revenue and profit growth rates?
Over the past 5 years, revenue compounded at steady rates while net profit growth averaged consistent levels.
Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.
Market data may be delayed. Quote date: 2026-10-16. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.

